Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookie, but we will activate these services only with your consent. If you press the button “Accept”, you consent to the use of these analytics scripts.

You can withdraw your consent at any time. To do so, please modify your configurations on this website by following this link to our privacy statement with the configuration options:
Go to settings



Responsible Use of Opioids

The Grünenthal charter
on the responsible use of opioids

As a leading manufacturer of pain treatments including opioids, Grünenthal is aware that, besides the benefits these medicines can provide, they also carry risks – for instance inappropriate use, misuse, abuse, addiction (opioid use disorder, OUD) and diversion. We share the broad consensus with the pain community that the opioid crisis in some countries needs to be addressed with high urgency.

Grünenthal’s charter on the responsible use of opioids (summarized below) sets out our continuing commitment to explore and endorse measures that minimize the risk of inappropriate and illegitimate use of prescription opioids – while striving to ensure that individual patients with a clear need for opioid-based pain relief are not denied access.